Contact Us
Contact Us
Home Finance AbbVie reports positive Crohn’s disease trial results for Skyrizi
Finance

AbbVie reports positive Crohn’s disease trial results for Skyrizi

October 13, 20261 Mins read0
Share
AbbVie reports positive Crohn’s disease trial results for Skyrizi
Share


AbbVie reports positive Crohn’s disease trial results for Skyrizi

Source link

Share
5e advanced materials director Graham van’t Hoff buys 5,400 in shares Previous post 5e advanced materials director Graham van’t Hoff buys $215,400 in shares

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Solitron Devices sees Q2 profit surge YoY as net bookings increase
Finance

Solitron Devices sees Q2 profit surge YoY as net bookings increase

ByOctober 13, 2026
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.35%
Finance

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.35%

ByOctober 13, 2026
TriNet adds leave management, recruiting tools to platform
Finance

TriNet adds leave management, recruiting tools to platform

ByOctober 13, 2026
Biomea Fusion reports weight loss data from oral GLP-1 trial
Finance

Biomea Fusion reports weight loss data from oral GLP-1 trial

ByOctober 13, 2026
© Copyright 2024 Jellywp. All rights reserved powered by Jellywp.com